Hunter syndrome (mucopolysaccharidosis type II): Molecular mechanisms, CNS biomarkers, and emerging therapeutic strategies

Experimental and Molecular Pathology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles